Category: Medical
-
STAT+: South Africa is urged by advocates to issue a compulsory license for Gilead’s HIV prevention drug
•
Patient advocacy groups have urged the South African government to issue a compulsory license for a groundbreaking HIV…
-
STAT+: Pfizer’s mRNA-based flu shot offered better protection than standard vaccine
•
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter…
-
STAT+: Pharmalittle: We’re reading about a Pfizer settlement with Texas, Agios sickle cell drug results, and more
•
Good morning, everyone, and how are you today? We are doing just fine, thank you, especially since a…
-
STAT+: Pfizer and Tris agree to $41.5 million settlement with Texas over ADHD drug for children
•
Pfizer and Tris Pharma have agreed to pay $41.5 million to settle allegations by Texas Attorney General Ken…
-
STAT+: Novo nears release of high-stakes data on Alzheimer’s and GLP-1s
•
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter…
-
STAT+: Pharmalittle: We’re reading about a Novo drug and Alzheimer’s, a Sarepta drug warning, and more
•
Hello, everyone, and how are you today? The skies over the Pharmalot campus are soggy this morning, but…
-
STAT+: Novo Nordisk’s $199 Ozempic deal shows what telehealth platforms can do for pharma
•
On Monday, Novo Nordisk announced a discount on its popular drugs for diabetes and obesity, Ozempic and Wegovy,…
-
STAT+: A revelatory profile of RFK Jr.
•
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health…
-
Judge approves opioid settlement for Purdue Pharma and Sackler family members who own the company
•
A federal bankruptcy court judge on Tuesday formally approved OxyContin maker Purdue Pharma’s plan to settle thousands of lawsuits over…
-
STAT+: FDA’s stronger warning on Sarepta gene therapy raises new questions about heart risk
•
New warnings and restrictions placed on Sarepta Therapeutics’ gene therapy last week by the Food and Drug Administration…
-
STAT+: Vaccine makers have reason for alarm in proposals to reformulate shots
•
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter…
-
STAT+: Pharmalittle: We’re reading about warnings from vaccine makers, the U.K. standoff with pharma, and more
•
Top of the morning to you, and a fine one it is. Clear blue skies and pleasant breezes…
-
STAT+: Trump administration touts moves to provide HIV prevention drug, but refuses to include South Africa
•
Touting a commitment to provide a groundbreaking HIV prevention drug to poor countries, the U.S. Department of State…
-
STAT+: Trump and RFK Jr. are mulling their most disruptive vaccine policies yet — alarming manufacturers
•
WASHINGTON — As the Trump administration moves ahead on what could be its most wide-reaching vaccine changes yet,…
-
STAT+: Many poor countries where experimental drugs are tested fail to benefit after approval, analysis finds
•
Numerous medicines are not accessible in many of the countries where they were tested before approval by the…
-
STAT+: Johnson & Johnson acquires Halda Therapeutics for $3 billion, a big win for a buzzy new technology
•
Johnson & Johnson said Monday it will purchase Halda Therapeutics and its experimental prostate cancer drugs for $3.05…
Recent Posts
- How March Madness foes can end UConn’s run through bracket
- Tournament bets: 12-over-5 upset pick and the 2-seed with clearest path to Elite Eight
- March Madness: Odds, spreads and totals for every men’s opening round games
- One Battle After Another’s big night: Key takeaways from the 2026 Oscars
- Liberia: LDEA Seizes Drugs Worth L$7.77 Million At Ganta Border – Guinean National Arrested
- Nigeria: Why I Didn’t Panic After Losing Power – Sanusi
- Liberia: Police Declare Jackson’s Home ‘Restricted’ As Crime Scene Reconstruction Continues in Wife’s Death Probe
- Liberia: NCD Launches Historic Nationwide Tour to Assess Needs of Persons With Disabilities
- Liberia: CDC Raises Concern Over Foya Border Tension and Accuses Government of Risking National Peace
- Nigeria: 2027 – Tinubu Directs His Campaign Group to Donate Rice to Nigerians for Ramadan, Lent
- Nigeria: Mining Dispute – Govt Accuses Jupiter Ltd of Smear Campaign Plot During Tinubu’s UK Visit
- Nigeria: Nigerian Govt Denies ‘British Lithium Project’ Seizure, Alleges Smear Campaign Ahead of Tinubu’s UK Visit
Social Media
Advertisement
